Article
The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.
Endocrine pathology - 1 Mar 2017
Grey William, Hulse Rosaline, Yakovleva Anna, Genkova Dilyana, Whitelaw Benjamin, Solomon Ellen, Diaz-Cano Salvador J, Izatt Louise
Abstract excerpt
The REarranged during Transfection (RET) proto-oncogene is a receptor tyrosine kinase involved in growth and differentiation during embryogenesis and maintenance of the urogenital and nervous systems in mammals. Distinct mutations across hotspot RET exons can cause Multiple Endocrine Neoplasia Type 2A (MEN2A) characterised by development of medullary thyroid cancer (MTC), phaeochromocytoma (PCC) and primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
